Hexagon Nutrition IPO
Historical offer record. This offer is closed for applications. Prices and subscriptions describe the past offer; GMP observations are unofficial past records, not current quotes or listing predictions.
Data provider: FinAPI. This is a third-party summary, not an official prospectus. Read our data limitations and editorial policy.
Price band
₹42 – ₹45
Lot size
333 shares
Offer application amount
₹14,985
Issue size
₹138.87 Cr
Historical offer amount for 1 lot at the upper issue price. Confirm the lot size and application terms in the issuer prospectus.
Reported IPO schedule
| Open date | 5 Jun 2026 |
| Close date | 9 Jun 2026 |
| Allotment finalisation | 10 Jun 2026 |
| Refund initiation | 11 Jun 2026 |
| Shares credited to demat | 11 Jun 2026 |
| Reported listing date | 12 Jun 2026 |
Historical GMP observations
GMP is an unofficial, unregulated indicator and not a reliable predictor of listing price. Observations supplied by FinAPI; an underlying GMP source link was not provided.
About Hexagon Nutrition
Hexagon Nutrition Limited, founded in 1993, is one of the leading nutrition companies in India. The firm focuses on developing and manufacturing across 3 verticals: Micronutrient Premix Products, Clinical Nutrition, and Therapeutic Foods. The company runs its 3 manufacturing facilities in India, located at Nasik, Chennai, and Thoothukudi, as well as an international facility in Tashkent, Uzbekistan. Its product portfolio is divided into 3 segments:
Company summary supplied by FinAPI. Read the prospectus for the issuer's disclosures and audited financials.
Offer documents and primary references
Read the issuer's offer document and any corrigenda for the full disclosures. A third-party details page is a summary; SEBI filing access does not imply an endorsement of the offer or this website.
IPO information is sourced from public feeds and shown for general information only. It is not a recommendation to apply for this or any IPO. IPOs are equity investments and carry market risk; listing gains are not guaranteed and SME IPOs are especially volatile. Grey Market Premium (GMP) is unofficial and not endorsed by SEBI or the exchanges. Equity IPOs are applied for through a demat and trading account, not through mutual fund distribution services. Read the RHP and consult a SEBI-registered investment adviser before investing.